HUP9801220A2 - Fumagillol és származékai alkalmazása bélfertőzések kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Fumagillol és származékai alkalmazása bélfertőzések kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP9801220A2
HUP9801220A2 HU9801220A HUP9801220A HUP9801220A2 HU P9801220 A2 HUP9801220 A2 HU P9801220A2 HU 9801220 A HU9801220 A HU 9801220A HU P9801220 A HUP9801220 A HU P9801220A HU P9801220 A2 HUP9801220 A2 HU P9801220A2
Authority
HU
Hungary
Prior art keywords
fumagillol
derivatives
intestinal infections
preparing medicaments
against intestinal
Prior art date
Application number
HU9801220A
Other languages
English (en)
Inventor
Francis Derouin
Jean-Michel Molina
Original Assignee
Assistance Publique-Hopitaux De Paris
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique-Hopitaux De Paris, Sanofi filed Critical Assistance Publique-Hopitaux De Paris
Publication of HUP9801220A2 publication Critical patent/HUP9801220A2/hu
Publication of HUP9801220A3 publication Critical patent/HUP9801220A3/hu
Publication of HU224028B1 publication Critical patent/HU224028B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)

Abstract

A találmány a fűmagillőlnak és a fűmagillőlnak telített vagytelítetlen, 1-12 szénatőmős alkil-karbőnsavakkal vagy 1-12 szénatőmősalkil-dikarbőnsavakkal alkőtőtt észtereinek és ezek gyógyszerészetilegalkalmazható sóinak a mikrőspőrídiűmők és/vagy kriptőspőrídiűmőkőkőzta bélfertőzések elleni gyógyszerek előállítására valóalkalmazására vőnatkőzik. ŕ
HU9801220A 1995-03-27 1996-03-26 Fumagillol és származékai alkalmazása bélfertőzések kezelésére szolgáló gyógyszerek előállítására HU224028B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503549 1995-03-27
PCT/FR1996/000448 WO1996030010A2 (fr) 1995-03-27 1996-03-26 Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales

Publications (3)

Publication Number Publication Date
HUP9801220A2 true HUP9801220A2 (hu) 1999-09-28
HUP9801220A3 HUP9801220A3 (en) 2001-10-29
HU224028B1 HU224028B1 (hu) 2005-05-30

Family

ID=9477436

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801220A HU224028B1 (hu) 1995-03-27 1996-03-26 Fumagillol és származékai alkalmazása bélfertőzések kezelésére szolgáló gyógyszerek előállítására

Country Status (25)

Country Link
US (1) US5900431A (hu)
EP (1) EP0817626B1 (hu)
JP (1) JP3260378B2 (hu)
KR (1) KR100286920B1 (hu)
CN (1) CN1072485C (hu)
AP (1) AP646A (hu)
AT (1) ATE172641T1 (hu)
AU (1) AU706161B2 (hu)
CA (1) CA2216623C (hu)
CZ (1) CZ286821B6 (hu)
DE (1) DE69600879T2 (hu)
DK (1) DK0817626T3 (hu)
EA (1) EA000150B1 (hu)
ES (1) ES2128846T3 (hu)
FR (1) FR06C0014I2 (hu)
HU (1) HU224028B1 (hu)
IS (1) IS2048B (hu)
NO (1) NO315968B1 (hu)
NZ (1) NZ304906A (hu)
OA (1) OA10515A (hu)
PL (1) PL183378B1 (hu)
SK (1) SK283883B6 (hu)
TR (1) TR199701048T1 (hu)
UA (1) UA41446C2 (hu)
WO (1) WO1996030010A2 (hu)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ304906A (en) * 1995-03-27 1999-06-29 Sanofi Sa Use of fumagillol or a fumagillol ester and an optionally saturated alkylcarboxylic or alkyldicarboxylic acid to fight intestinal infections
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
ATE361757T1 (de) 1999-02-26 2007-06-15 Sanofi Aventis Stabile fumagillin-formulierung
JP3265394B1 (ja) * 2001-03-14 2002-03-11 泰三 矢野 アクリル系樹脂手袋
DE10341887A1 (de) * 2003-09-09 2005-03-31 Leopold Kostal Gmbh & Co. Kg Elektrisches Schaltermodul
FR2886855B1 (fr) * 2005-06-08 2009-07-17 Agronomique Inst Nat Rech Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques
EP2217283A2 (en) * 2007-11-28 2010-08-18 Mersana Therapeutics, Inc. Biocompatible biodegradable fumagillin analog conjugates
NZ590732A (en) * 2008-07-18 2012-09-28 Zafgen Inc Methods of treating an overweight or obese subject using fumagillin
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
US20120004162A1 (en) 2008-12-04 2012-01-05 Vath James E Methods of Treating an Overweight or Obese Subject
KR20120083905A (ko) 2009-10-09 2012-07-26 자프겐 코포레이션 비만의 치료에 사용하기 위한 설폰 화합물
US8815309B2 (en) 2010-01-08 2014-08-26 Zafgen, Inc. Methods of treating a subject with benign prostate hyperplasia
MX343135B (es) 2010-01-08 2016-10-25 Zafgen Corp * Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
CN103249735B (zh) 2010-07-22 2016-04-06 扎夫根股份有限公司 三环化合物及其制备和使用方法
MX2013005208A (es) 2010-11-09 2013-08-01 Zafgen Inc Sólidos cristalinos de un inhibidor de metionina aminopeptidasa 2 y métodos para obtener y usar los mismos.
EP2646016B1 (en) 2010-11-29 2017-05-17 Zafgen, Inc. Treatment if obesity using non-daily administration of 6-0-(4-dimethylaminoethoxy)cinnamoyl fumagillol
BR112013018771A2 (pt) 2011-01-26 2019-09-17 Zafgen Inc compostos de tetrazol e métodos para fazer e usar os mesmos
AU2012225531B2 (en) 2011-03-08 2017-03-30 Zafgen, Inc Oxaspiro (2.5) octane derivatives and analogs
WO2012154679A1 (en) 2011-05-06 2012-11-15 Zafgen Corporation Tricyclic pyrazole sulfonamide compounds and methods of making and using same
US9290472B2 (en) 2011-05-06 2016-03-22 Zafgen, Inc. Partially saturated tricyclic compounds and methods of making and using same
CA2835195A1 (en) 2011-05-06 2012-11-15 Zafgen, Inc. Tricyclic sulfonamide compounds and methods of making and using same
EP2763671A2 (en) 2011-10-03 2014-08-13 Zafgen, Inc. Methods of treating age related disorders
US9440943B2 (en) 2012-01-18 2016-09-13 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
KR20140112565A (ko) 2012-01-18 2014-09-23 자프겐 인크. 삼환식 설폰아마이드 화합물 그리고 그의 제조방법 및 그를 이용하는 방법
AU2013259760A1 (en) 2012-05-07 2014-11-20 Zafgen, Inc. Polymorphic salt of the oxalate salt of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol and methods of making and using same
AU2013259617A1 (en) 2012-05-08 2014-11-27 Zafgen, Inc. Treating hypothalamic obesity with MetAP2 inhibitors
WO2013169860A1 (en) 2012-05-09 2013-11-14 Zafgen, Inc. Fumigillol type compounds and methods of making and using same
AU2013337288A1 (en) 2012-11-05 2015-05-21 Zafgen, Inc. Tricyclic compounds for use in the treatment and/or control of obesity
SG11201503521QA (en) 2012-11-05 2015-06-29 Zafgen Inc Methods of treating liver diseases
CA2890342A1 (en) 2012-11-05 2014-05-08 Zafgen, Inc. Tricyclic compounds and methods of making and using same
CA2904353A1 (en) 2013-03-14 2014-09-25 Zafgen, Inc. Methods of treating renal disease and other disorders
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106591389B (zh) * 2015-10-15 2019-10-11 中国科学院微生物研究所 一种利用烟曲霉菌生产烟曲霉素的方法
CN105622593B (zh) * 2016-02-25 2018-06-26 中国农业科学院蜜蜂研究所 一种烟曲霉素的提取方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2791530A (en) * 1953-08-31 1957-05-07 Abbott Lab Stabilized fumagillin compositions
JPH0629278B2 (ja) * 1985-06-26 1994-04-20 藤沢薬品工業株式会社 オキサスピロオクタン化合物
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
WO1992002240A2 (en) * 1990-07-27 1992-02-20 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
NZ304906A (en) * 1995-03-27 1999-06-29 Sanofi Sa Use of fumagillol or a fumagillol ester and an optionally saturated alkylcarboxylic or alkyldicarboxylic acid to fight intestinal infections
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
AU3968597A (en) * 1996-08-02 1998-02-25 Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors

Also Published As

Publication number Publication date
KR100286920B1 (ko) 2001-04-16
IS2048B (is) 2005-09-15
EA000150B1 (ru) 1998-10-29
CZ286821B6 (en) 2000-07-12
WO1996030010A2 (fr) 1996-10-03
CN1179715A (zh) 1998-04-22
CZ304997A3 (en) 1997-12-17
NO315968B1 (no) 2003-11-24
EP0817626A2 (fr) 1998-01-14
OA10515A (fr) 2002-04-24
CA2216623C (en) 2005-05-31
TR199701048T1 (xx) 1998-01-21
DE69600879D1 (de) 1998-12-03
US5900431A (en) 1999-05-04
UA41446C2 (uk) 2001-09-17
CN1072485C (zh) 2001-10-10
HU224028B1 (hu) 2005-05-30
MX9707150A (es) 1998-07-31
WO1996030010A3 (fr) 1996-11-28
SK130797A3 (en) 1998-03-04
DK0817626T3 (da) 1999-07-12
FR06C0014I1 (hu) 2006-11-17
IS4557A (is) 1997-09-11
NO974466L (no) 1997-09-26
JP3260378B2 (ja) 2002-02-25
NO974466D0 (no) 1997-09-26
ATE172641T1 (de) 1998-11-15
AU706161B2 (en) 1999-06-10
FR06C0014I2 (hu) 2006-12-29
JPH11506421A (ja) 1999-06-08
AU5278696A (en) 1996-10-16
HUP9801220A3 (en) 2001-10-29
NZ304906A (en) 1999-06-29
AP9701092A0 (en) 1997-10-31
ES2128846T3 (es) 1999-05-16
PL322470A1 (en) 1998-02-02
SK283883B6 (sk) 2004-04-06
KR19980703271A (ko) 1998-10-15
EP0817626B1 (fr) 1998-10-28
DE69600879T2 (de) 1999-06-02
EA199700267A1 (ru) 1998-04-30
PL183378B1 (pl) 2002-06-28
AP646A (en) 1998-04-27
CA2216623A1 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
HUP9801220A2 (hu) Fumagillol és származékai alkalmazása bélfertőzések kezelésére szolgáló gyógyszerkészítmények előállítására
MX9203677A (es) Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
MX9200269A (es) Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimientos para su preparacion
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
EG17609A (en) Process for preparation of therapeutic agents from derivatives of propoimic acid.
ES2058173T3 (es) Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion.
DE69011913D1 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung.
ATE110957T1 (de) Pharmazeutische behandlung einer augenentwicklung.
EP0369887A3 (fr) Utilisation de trifluorométhylphényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles anxio-dépressifs
AR010984A1 (es) Nuevos esteres de la pleuromutilina, y el acido 1-azabiciclo-4- carbanilcarbanico; procedimiento para su preparacion y composicionesfarmaceuticas que los contienen.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
MX9205132A (es) Derivados de acidos carboxilicos heterociclicos, procedimiento para su obtencion y medicamentos que los contienen.
HUP9901055A2 (hu) Eljárás klavulanátsók előállítására
ES2031854T3 (es) Nuevos acidos 4-quinoloncarboxilicos 1,8-puenteados y medicamentos que les contienen.
AU5060090A (en) Pharmaceutical treatment
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
FI893677A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
FI964303A0 (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
KR920007626A (ko) 벤조[b]티오펜-2-카르복시이미드아미드 유도체의 사용방법
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
SE9000948D0 (sv) New use
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050322